Esophageal plexiform fibromyxoma: A case report with molecular analysis for MALAT1-GLI1 fusion

Michiyo Higashi,Taiji Hamada,Ken Sasaki,Yusuke Tsuruda,Masataka Shimonosono,Ikumi Kitazono,Mari Kirishima,Takashi Tasaki,Hirotsugu Noguchi,Kazuhiro Tabata,Masanori Hisaoka,Yoshihiko Fukukura,Takao Ohtsuka,Akihide Tanimoto

DOI: https://doi.org/10.1016/j.prp.2022.153878

Abstract:Plexiform fibromyxoma (PFM) is a rare gastrointestinal tract tumor that develops in the stomach in most cases. Here, we report an extremely rare case of esophageal PFM. A female in her mid-30 s presented with difficulty in swallowing and breathing. Endoscopic examination revealed a submucosal tumor measuring approximately 45 × 50 mm in the upper thoracic esophagus. The biopsied specimen did not show definite histological evidence of gastrointestinal stromal tumors (GISTs). Since imatinib administration based on a clinical diagnosis of GIST did not show a therapeutic effect for tumor reduction, tumor resection was performed. The resected tumor exhibited proliferation of spindle tumor cells with abundant myxoid and vascular stroma separated by a muscular layer, indicating a plexiform arrangement. Immunohistochemical analysis demonstrated that the tumor cells diffusely expressed vimentin and alpha-smooth muscle actin, but not desmin, c-kit, DOG1, and CD34. MALAT1-GLI1 fusion was detected in formalin-fixed paraffin-embedded tissue using RT-PCR and Sanger sequencing. The results suggested that a fibromyxoid tumor can develop in the esophagus, showing an identical histology and MALAT1-GLI1 fusion to gastric PFM.